Poster Presentations Session IV
Poster Presentations Session IV Tuesday, 1 November 2016
POSTERS SET-UP: 15:00 - 15:15
POSTERS DISPLAY HOURS: 15:15 - 19:15
POSTER AUTHOR DISCUSSION: 18:15 - 19:15
POSTERS DISMANTLE: 19:15


Poster display locations are shown below the poster codes
HEALTH SERVICES - Clinical Outcomes Studies
PHS1
A1
HERPES ZOSTER-ASSOCIATED RESOURCES CONSUMPTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
Muñoz-Quiles C, López-Lacort M, Díez-Domingo J
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO-Public Health, Valencia, Spain

PHS2
A2
UPTAKE OF HEPATITIS B HIV CO-INFECTION SCREENING AND MANAGEMENT IN A RESOURCE LIMITED SETTING
Musomba R1, Castelnuovo B1, Murphy C2, Komujuni C1, Nyakato P1, Ocama P1, Larmode M3, Ratanshi RP3
1Infectious Diseases Institute, College of Health Sciences Makerere University, Kampala, Uganda, 2Queen Elizabeth University Hospital, Scotland, UK, 3Infectious Diseases Institute, College of Health Sciences Makerere University.re, Kampala, Uganda

PHS3
A3
AN INDIRECT COMPARISON BETWEEN ADALIMUMAB, BARICITINIB AND TOFACITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Migliore A
s.Pietro Hospital, Rome, Italy

PHS4
A4
A NETWORK METANALYSIS TO COMPARE BIOLOGIC AGENTS IN THE TREATMENT OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Migliore A
S.Pietro Fatebenefratelli Hospital, rome, Italy

PHS5
A5
COMPARISON OF MORTALITY REDUCTION FROM GASTRIC CANCER AMONG DIFFERENT SCREENING PROGRAMS
Hamashima C1, Narisawa R2, Ogoshi K2
1National Cancer Center, Tokyo, Japan, 2Niigata Cancer Center Hospital, Niigata, Japan

PHS6
A6
EFFECTIVENESS AND COST-EFFECTIVENESS OF THE SALUT PROGRAMME – A UNIVERSAL HEALTH PROMOTION INTERVENTION FOR PARENTS AND CHILDREN
Sampaio F1, Feldman I1, Eurenius E2, Häggström J2, Lindkvist M2, Pulkki-Brännström A2, Ivarsson A2
1Uppsala University, Uppsala, Sweden, 2Umeå University, Umeå, Sweden

PHS7
A7
CLINICAL AND COMPARATIVE EFFECTIVENESS OF TELEMONITORING INTERVENTION VERSUS USUAL CARE FOR TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Park DA, Kim YJ, Park JE
National Evidence-based Healthcare Collaborating Agency, Seoul, South Korea

PHS8
A8
EFFECTIVENESS OF A RENAL PROTECTION PROGRAM IN PATIENTS WITH HYPERTENSION AND/OR DIABETES MELLITUS TYPE II IN COLOMBIA
Guarin NE1, Moreno JA1, Arévalo HO1, Muñoz-Galindo IM1, Diaz JA2
1Salud Total EPS, Bogotá D.C., Colombia, 2Universidad Nacional de Colombia, Bogotá D.C., Colombia

PHS9
A9
PREVALENCE, POTENTIAL RISK FACTORS, SEQUELAE OF DIASTASIS RECTI ABDOMINIS AND THE TREATMENT
Gitta S1, Magyar Z2, Palancsa M1, Tardi P3, Füge I1, Járomi M1, Ács P1, Boncz I1, Hock M1
1University of Pécs, Pécs, Hungary, 2Sándor Péterfy Hospital and Casualty Centre, Budapest, Hungary, 3Train-Health Nonprofit Ltd., Harkány, Hungary

PHS10
A10
IMPACT OF INITIATION OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS ON RESOURCE UTILIZATION IN PATIENTS WITH SCHIZOPHRENIA
Lachaine J1, Larbi M2, Melnyk P3, Rouleau A4, Baribeau V5, Stip E6
1University of Montreal, Montreal, QC, Canada, 2Lundbeck, Montreal, QC, Canada, 3Otsuka Canada Pharmaceutical Inc., Saint-Laurent, QC, Canada, 4Lundbeck SAS, Issy-les-Moulineaux, France, 5PeriPharm Inc., Montreal, QC, Canada, 6CHUM Research Center, Montreal, QC, Canada

PHS11
A11
EVALUATING FACTORS ASSOCIATED WITH DEPRESSIVE SYMPTOMS AMONG POSTPARTUM MOTHERS IN SOUTH PUNJAB, PAKISTAN
Zia A, Masood I
The Islamia University of Bahawalpur, Bahawalpur, Pakistan

PHS12
A12
CAESAREAN SECTION IN XINDU COUNTY OF CHENGDU, CHINA: TREND AND ITS CORRELATES FROM 2008 TO 2014
Zhu P1, Pan X1, Li C1, Wang Y1, Chen J1, Qi X2, Yang C1
1Sichuan University, Chengdu, China, 2West China secoond hospital, Chengdu, China

HEALTH SERVICES - Cost Studies
PHS13
A13
THE USE OF A DABIGATRAN-SPECIFIC REVERSAL AGENT: BUDGET IMPACT ANALYSIS FROM THE HOSPITAL PERSPECTIVE AND THE FRENCH PUBLIC PAYER PERSPECTIVE
Jamet N1, Bourguignon S2, Le Lay K3
1STRATEGIQUE SANTE, Evry, France, 2Stratégique Santé, Evry, France, 3Boehringer Ingelheim France, Paris, France

PHS14
A14
CLINICAL AND ECONOMIC ANALYSIS OF EYELID HYGIENE COMPLEX FOR PATIENTS WITH MEIBOMIAN GLANDS DYSFUNCTION IN RUSSIA
Trubilin VN1, Polunina EG1, Markova EY2, Bezmelnitsyna LY3, Meshkov DO3
1Federal Medical and Biological Agency, Moscow, Russian Federation, 2Pirogov Russian National Research Medical University, Moscow, Russian Federation, 3National Research Institution for Public Health, Moscow, Russia

PHS15
A15
COST-EFFECTIVENESS OF PROGRAMS FOR EARLY DIAGNOSTICS OF REFRACTIVE ERRORS FOR CHILDREN IN RUSSIA
Markova EY1, Bezmelnitsyna LY2, Kurganova OV1, Khabriev RU2, Meshkov DO2
1Pirogov Russian National Research Medical University, Moscow, Russia, 2National Research Institution for Public Health, Moscow, Russia

PHS16
A16
MEASURING THE RELATIONSHIP BETWEEN HOSPITAL COSTS AND QUALITY OF CARE: AN EXAMPLE OF ACUTE MYOCARDIAL INFRACTION IN EDMONTON, ALBERTA, CANADA
Chu F, Ohinmaa A, Kaul P
University of Alberta, Edmonton, AB, Canada

PHS17
A17
SOCIETAL IMPACT OF ONE-TIME SCREENING FOR DIABETES AT AGE 30 IN THE INDIAN POPULATION: A COST-EFFECTIVENESS ANALYSIS
Nagarajan M, Padula WV
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

PHS18
A18
DIRECT MEDICAL COSTS ASSOCIAED WITH DIABETIC COMPLICAITONS IN PATIENTS WITH TYPE 2 DIABETES IN US AND SOUTH KOREA
Chang C1, Barone J2, Je S1, Lee S1, Suh D1
1Chung-Ang University, Seoul, South Korea, 2Rutgers University, Piscataway, NJ, USA

PHS19
A19
INTRAVENOUS FLUIDS FOR CHILDREN: COST AND THRESHOLD ANALYSIS TO INFORM THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) CLINICAL GUIDELINE RECOMMENDATION
Dawoud D1, Fenu E1, Griffin EA1, Wonderling D1, Ritchie G1, Crean P2
1National Guideline Centre, Royal College of Physicians, London, UK, 2Royal Belfast Hospital for Sick Children, Belfast, UK

PHS20
A20
A COMPARATIVE COST ANALYSIS ON PERITONEAL DIALYSIS VERSUS HEMODIALYSIS IN TAIWAN
Tang C1, Kuo C2, Huang K2, Sue Y2
1School of Health Care Administration, Taipei Medical University, Taipei, Taiwan, 2Taipei Medical University, Taipei, Taiwan

PHS21
A21
WITHDRAWN

PHS22
A22
COMPARING COSTS FROM A PRAGMATIC RANDOMISED TRIAL TO PUBLISHED MODELLING-BASED ESTIMATES: AN EXAMPLE FROM PROSTATE-CANCER SCREENING
Booth N
University of Tampere, Tampere, Finland

PHS23
A23
LONG-TERM HEALTH CARE COST IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE: RESULTS FROM A SWEDISH NATIONWIDE STUDY
Sigvant B1, Kragsterman B2, Falkenberg M3, Hasvold P4, Johansson S5, Rikner K6, Thuresson M7, Nordanstig J3
1Department of Vascular Surgery, Karlstad Central Hospital, Karlstad, Sweden, 2Uppsala University, Uppsala, Sweden, 3Sahlgrenska Academy, Gothenburg, Sweden, 4AstraZeneca, Södertälje, Sweden, 5AstraZeneca Gothenburg, Mölndal, Sweden, Gothenburg, Sweden, 6AstraZeneca Gothenburg, Mölndal, Sweden, Mölndal, Sweden, 7Statisticon, Uppsala, Sweden

PHS24
A24
THE BURDEN OF ILLNESS IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER WITH BONE METASTASES IN ASIA PACIFIC (AUSTRALIA, SOUTH KOREA, AND TAIWAN)
Gemmen E1, Patil DS2
1Real-World & Late Phase Research, Quintiles, Inc., Rockville, MD, USA, 2Quintiles Inc, Rockville, MD, USA

PHS25
A25
THE ECONOMIC IMPACT OF SCHIZOPHRENIA FROM AN ENGLISH NHS PERSPECTIVE BASED ON ESTIMATES FROM ELECTRONIC AND SELF-REPORTED METHODS OF DATA COLLECTION
Franklin M1, Tran I2, Stoneman D2, Watson S3
1University of Sheffield, Sheffield, UK, 2Roche Products Ltd, Welwyn Garden City, UK, 3Newcastle University, Newcastle, UK

PHS26
A26
THE PRESCRIBING, INPATIENT, OUTPATIENT AND SOCIAL CARE COSTS ASSOCIATED WITH ATRIAL FIBRILLATION IN SCOTLAND: A RECORD LINKAGE STUDY
Ciminata G, Geue C, Langhorne P, Wu O
University of Glasgow, Glasgow, UK

PHS27
A27
CLINICAL OUTCOME AND HEALTH CARE COSTS OF BLOOD STREAM INFECTIONS WITH RESISTANT KLEBSIELLA PNEUMONIAE IN PEDIATRIC PATIENTS
Tanır Basaranoglu S, Aykac K, Ozsurekci Y, Karadag Oncel E, Ceyhan M
Hacettepe University, Ankara, Turkey

PHS28
A28
THE BURDEN OF ILLNESS OF MYCOSIS FUNGOIDES CUTANEOUS T-CELL LYMPHOMA: A RETROSPECTIVE COHORT STUDY OF A COMMERCIALLY INSURED POPULATION IN THE U.S
Gu T1, Raspa S2, Tsang Y3, Drake W2
1HealthCore Inc., Wilmington, DE, USA, 2Actelion Pharmaceuticals, Inc., South San Francisco, CA, USA, 3Actelion Pharmaceuticals Ltd., South San Francisco, CA, USA

PHS29
A29
LONG-TERM HEALTHCARE COSTS OF PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE WITH AND WITHOUT A HISTORY OF ATHEROSCLEROTIC DISEASE: RESULTS FROM A SWEDISH NATIONWIDE STUDY
Sigvant B1, Kragsterman B2, Falkenberg M3, Hasvold P4, Johansson S5, Rikner K6, Thuresson M7, Nordanstig J3
1Department of Vascular Surgery, Karlstad Central Hospital, Karlstad, Sweden, 2Uppsala University, Uppsala, Sweden, 3Sahlgrenska Academy, Gothenburg, Sweden, 4AstraZeneca, Södertälje, Sweden, 5AstraZeneca Gothenburg, Mölndal, Sweden, Gothenburg, Sweden, 6AstraZeneca Gothenburg, Mölndal, Sweden, Mölndal, Sweden, 7Statisticon, Uppsala, Sweden

PHS30
A30
COMPARING THE HOSPITALIZATION AND REHOSPITALIZATION EXPENDITURES OF MYOCARDIAL INFARCTION PATIENTS IN BEIJING, 2012-2013
Wen L1, Yang L1, Liu Y2, Wu J1
1Peking University, Beijing, China, 2The University of Missouri – Kansas City, Kansas City, MO, USA

PHS31
A31
BURDEN OF DIVERTICULAR DISEASE: AN OBSERVATIONAL ANALYSIS BASED ON ITALIAN REAL WORLD DATA
Sciattella P1, Mennini FS2, Marcellusi A3, Toraldo B4, Koch M5
1Faculty of Economics, Centre for Economic and International Studies (CEIS)-Economic Evaluation and HTA (EEHTA), University of Rome Tor Vergata, Rome, Italy, 2University of Rome Tor Vergata, Rome, Italy, 3National Research Council (CNR), Rome, Italy, 4Alfa Wassermann Italia, Bologna, Italy, 5S. Filippo Neri Hospital, Rome, Italy

PHS32
A32
EVALUATION OF THE DIRECT COSTS OF HEALTH CARE DURING THE FIRST YEAR OF LIFE OF BABIES BORN WITH MICROCEPHALY IN THE SUS
Zanghelini F, Pitta MG, Andrade CA
Universidade Federal de Pernambuco, Recife, Brazil

PHS33
A33
THE MANAGEMENT AND COSTS OF MULTIPLE MYELOMA IN GREECE: MAPPING THE LOCAL TREATMENT PATHWAY AND ASSOCIATED RESOURCE USE
Siskou O1, Kaitelidou D2, Delimpasi S3, Katodritou E4, Megalakaki K5, Pouli A6, Repousis P5, Terpos E7, Kalogeropoulou M8, Florini S8, Konstantakopoulou O1, Goranitis I9, Liaropoulos L1, Dimopoulos MA10
1Center for Health Services Management and Evaluation, National and Kapodistrian University of Athens, Athens, Greece, 2Open University of Cyprus, Latsia, Nicosia, Cyprus, 3Evangelismos Hospital, ATHENS, Greece, 4Theagenion Anticancer Hospital, Thessaloniki, Greece, 5Metaxa Anticancer Hospital, Pireaus, Greece, 6Agios Savvas Anticancer Hospital, ATHENS, Greece, 7National and Kapodistrian University of Athens, ATHENS, Greece, 8NOVARTIS HELLAS, Metamorfosi, Greece, 9College of Medical and Dental Sciences University of Birmingham, Birmingham, UK, 10National and Kapodistrian University of Athens, Athens, Greece

PHS34
A34
EPIDEMIOLOGY, TREATMENT PATHWAYS AND COSTS OF CANCERS POTENTIALLY RELATED TO HPV INFECTION IN FRANCE
Abramowitz L1, Lacau Saint Guily J2, Moyal-Barracco M3, Jacquard A4, Largeron N5, Dahlab A5, Uhart M5, Bresse X5, Bergeron C6, Borne H7, Cancalon C8, Catella L8, Bénard S8
1Hôpital Bichat - Claude Bernard, Paris, France, 2Hôpital Tenon, Paris, France, 3Dermatologist, Paris, France, 4Sanofi Pasteur MSD France, Lyon, France, 5Sanofi Pasteur MSD, Lyon, France, 6Laboratoire Cerba, Saint-Ouen-l'Aumône, France, 7Gynecologist, Paris, France, 8st[è]ve consultants, Oullins, France

PHS35
A35
NEW DATA ON THE BURDEN OF ABNORMAL PAP SMEARS AND HOSPITALISED PRE-CANCEROUS LESIONS IN FRANCE (EGB AND PMSI DATABASES ANALYSIS)
Catella L1, Cancalon C1, Lafourcade A2, de Rycke Y2, Guillo S2, Tubach F3, Dalichampt M4, Jacquard A5, Largeron N6, Dahlab A6, Uhart M6, Bresse X6, Bergeron C7, Borne H8, Bénard S1
1st[è]ve consultants, Oullins, France, 2NSERM UMR 1123 ECEVE, Hôpital Bichat Claude Bernard, Paris, France, 3APHP, Département d'Epidémiologie et Recherche Clinique CIC-EC 1425, Centre de Pharmacoépidémiologie (Cephepi); University Paris Diderot, Sorbonne Paris Cité, Unité Mixte de Recherche (UMR) 1123: Epidémiologie clinique, évaluation économique et population, Paris, France, 4Biostatistician, Nantes, France, 5Sanofi Pasteur MSD France, Lyon, France, 6Sanofi Pasteur MSD, Lyon, France, 7Laboratoire Cerba, Saint-Ouen-l'Aumône, France, 8Gynecologist, Paris, France

PHS36
A36
STUDY CARE COSTS AND USE OF HEALTH TECHNOLOGIES FOR PATIENTS WITH HEMOPHILIA A HEALTH SYSTEM AFFILIATES IN COLOMBIA
Acuna L1, Bryon A2, Espin J3
1Cuenta de Alto Costo, Bogota, Colombia, 2HEORT, Bogota, Colombia, 3Andalusian School of Public Health, Granada, Spain

PHS37
A37
HEALTH INSURANCE TREATMENT COST OF COLORECTAL CANCER IN HUNGARY
Boncz I1, Zemplényi A1, Horváthné Kívés Z1, Vajda R1, Kovács A2, Budai A2, Endrei D1
1University of Pécs, Pécs, Hungary, 2National Public Health and Medical Officers Service (ÁNTSZ), Budapest, Hungary

PHS38
A38
QUANTIFYING THE ECONOMIC BURDEN OF CHRONIC SPONTANEOUS URTICARIA IN PORTUGAL – WHAT IS THE IMPACT ON THE PORTUGUESE NHS AND IN THE SOCIETY
Moital I1, Carrasco J2, Rodrigues Martins A1
1Novartis Farma, Porto Salvo, Portugal, 2Novartis Farma Portugal, Porto Salvo, Portugal

PHS39
B1
COLORECTAL CANCER TREATMENT COSTS IN ESTONIA
Männik A1, Suuroja T2, Kiivet R1
1University of Tartu, Tartu, Estonia, 2The North Estonia Medical Centre, Tallinn, Estonia

PHS40
B2
SOCIETAL AND-ECONOMIC BURDEN OF IRON DEFICIENCY AMONG SWISS WOMEN – RESULTS FROM A HOUSEHOLD SURVEY
Blank PR1, Szucs TD2, Schwenkglenks M2, Tomonaga Y1
1University of Zurich, Zurich, Switzerland, 2European Center of Pharmaceutical Medicine - University of Basel, Basel, Switzerland

PHS41
B3
ADVANCED RENAL CELL CARCINOMA IN PREVIOUSLY TREATED PATIENTS: MEASURING HEALTHCARE USE, PRODUCTIVITY LOSS AND COSTS
Sousa G1, Mansinho H2, Figueiredo A3, Fraga A4, Sousa N5, Almeida AJ6
1IPO Coimbra, Coimbra, Portugal, 2Hospital Garcia de Orta, Almada, Portugal, 3Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 4Hospital Geral de Santo António, Porto, Portugal, 5IPO Porto, Porto, Portugal, 6Bristol-Myers Squibb, Paço de Arcos, Portugal

PHS42
B4
TOWARDS BETTER COORDINATION AND MORE EFFICIENT PATIENT PATHWAYS IN COPD
Devillier P1, Dorizon D2, Nachbaur G2, Hudry J2, Antoun Z2
1UPRES EA220, Hôpital Foch, Suresnes, France, 2GlaxoSmithkline, Marly le roi, France

PHS43
B5
OUTCOMES FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): MULTIPLE HOSPITALIZATIONS AND HIGH MORTALITY RATES
Sacks NC1, Miller DJ2, Louie AC2, Chiarella MT2, Cyr P1, Sharma A1, Liu Y1
1Precision Health Economics, Boston, MA, USA, 2Celator Pharmaceuticals, Inc., Ewing, NJ, USA

PHS44
B6
FACING CHALLENGES FOR A COST COMPARISON OF DAY SURGICAL AND INPATIENT VARICOSE VEIN SURGERY
Fischer S
Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria

PHS45
B7
HOSPITALIZATION COST AND LENGTH OF STAY ASSOCIATED WITH HPV-RELATED DISEASES
Tsakeu E1, Petit C2, Chevalier P1
1IMS Health, Zaventem, Belgium, 2Sanofi-Pasteur MSD, Diegem, Belgium

PHS46
B8
CLINICAL AND ECONOMIC BENEFITS OF A COMMUNITY PHARMACY VACCINATION STRATEGY
Gallagher J1, Byrne S1, O'Dwyer SM2, O'Reilly P2, McCarthy S1
1University College Cork, Cork, Ireland, 2Boots Ireland, Dublin 12, Ireland

PHS47
B9
SOCIAL RETURN ON INVESTMENT IN PSORIASIS
Villoro R1, Hidalgo A2, González A1, Jiménez M1, Ivanova Y1, Merino M1, Alfonso-Zamora S3, Carretero G4, Ledesma A5, Blanch C6, Expert Group on SROI-Psoriasis .7
1Instituto Max Weber, Madrid, Spain, 2University of Castilla-La Mancha, Toledo, Spain, 3Acción Psoriasis, Barcelona, Spain, 4Spanish Academy of Dermatology and Venereology, Madrid, Spain, 5Government of Catalonia, Barcelona, Spain, 6Novartis Pharmaceuticals, Barcelona, Spain, 7SROI-Psoriasis Group, Madrid, Spain

PHS48
B10
ASSOCIATION BETWEEN COPAYMENT, MEDICATION ADHERENCE AND OUTCOMES IN THE MANAGEMENT OF PATIENTS WITH DIABETES AND HEART FAILURE
Gourzoulidis G1, Kourlaba G2, Stafylas P3, Giamouzis G4, Parisis J5, Maniadakis N6
1EVROSTON, Athens, Greece, 2EVROSTON LP, Athens, Greece, 3Medical & Research Innovation LP, Thessaloniki, Greece, 4Larissa Univerity Hospital, Larissa, Greece, 5Athens Univeristy Hospital Attikon, Athens, Greece, 6National School of Public Health, Athens, Greece

PHS49
B11
COST EFFECTIVENESS EVALUATION OF FRACTURE LIAISON SERVICES FOR THE MANAGEMENT OF OSTEOPOROSIS IN SWEDEN
Jonsson E1, Borgström F1, Ström O2
1Quantify Research, Stockholm, Sweden, 2Karolinska Institutet, Stockholm, Sweden

PHS50
B12
COST-EFFECTIVENESS ANALYSIS OF COMPREHENSIVE MEDICATION REVIEW (CMR) FOR PATIENTS ACUTELY ADMITTED TO HOSPITAL
Szymanski T1, Reed J2, Holger Ehlers L3, Bell D2
1Imperial College London, London, UK, 2NIHR CLAHRC Northwest London, London, UK, 3Aalborg University, Aalborg, Denmark

PHS51
B13
COST-EFFECTIVENESS OF THE PHARMACIST-ASSISTED WARFARIN MONITORING PROGRAM (PAWM) AT A MEDICAL CENTER IN TAIWAN
Chang J1, Kang H2, Shen L1, Wang C1
1National Taiwan University, Taipei, Taiwan, 2National Taiwan University Hospital, Taipei, Taiwan

PHS52
B14
ECONOMIC ANALYSIS OF SCALING UP ACCESS TO MODERN FAMILY PLANNING METHODS IN LOW AND MIDDLE-INCOME COUNTRIES; CASE STUDIES FOR INDONESIA AND UGANDA
Zakiyah N1, van Asselt A1, Cao Q1, Setiawan D1, Roijmans F2, Postma MJ1
1University of Groningen, Groningen, The Netherlands, 2i+Solutions, Woerden, The Netherlands

PHS53
B15
HAVE THE NHS HEALTH CHECKS BEEN UNFAIRLY MALIGNED?
Hinde S, Bojke L, Richardson G
University of York, Heslington, UK

PHS54
B16
WITHDRAWN

PHS55
B17
HEALTHCRE REFORM PLAN AND PRICE ELASTICITY IN VAGINAL DELIVERY: A CASE STUDY IN IRAN
Afshari S1, Akbari-Sari A2, Soleymani F1, Raei B2
1tehran univercity of medical science, tehran, Iran, 2Tehran University of Medical Sciences, Tehran, Iran

PHS56
B18
INFLAMMATORY BACK PAIN: IMPACT ON WORKING HOURS, AND QUALITY OF LIFE AT 12 MONTHS
Moorthy A1, Wade A2, Crawford C2, Goyal A3
1University Hospitals of Leicester NHS trust, Leicester, UK, 2Patient Direct, Glasgow, UK, 3Abbvie, Maiden Head, UK

PHS57
B19
THE ECONOMIC BURDEN OF MULTIPLE SCLEROSIS IN SPAIN: A POPULATION BASED STUDY
Sicras-Mainar A1, Ruiz-Beato E2, Mauriño J3, Ferrer V4, Saez-Zafra M5, Sanchez L6, Navarro-Artieda R7
1EAP Vicenç Papaciet, La Roca del Vallés., Barcelona, Spain, 2HEOR Department, Roche Farma S.A, Madrid, Spain, 3Roche Farma S.A., Madrid, Spain, 4EAP Vicenc Papaciet, La Roca del Vallés, Barcelona, Spain, 5Research Group on Statistics, Econometrics and Health (GRECS), Universidad de Girona, Girona, Spain, 6Atención Primaria, Aviles, Asturias, Spain, 7Documentación Médica,Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

PHS58
B20
ASSURE-CSU: RESOURCE USE AND ECONOMIC BURDEN IN PATIENTS WITH REFRACTORY CHRONIC SPONTANEOUS/IDIOPATHIC URTICARIA IN ITALY
Roccia A1, Rigoni L1, Cawson MR2, McBride D2, Canonica GW3, Balp M4
1Novartis Farma, Origgio, Italy, 2RTI Health Solutions, Manchester, UK, 3University of Genoa, Genoa, Italy, 4Novartis Pharma AG, Basel, Switzerland

PHS59
B21
HEALTH CARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH THE MANAGEMENT OF NON-INFECTIOUS INTERMEDIATE, POSTERIOR AND PANUVEITIS IN CANADA
Lambert-Obry V1, Gouault-Laliberté A2, Castonguay A2, Aubin M3, Vadboncoeur J1, Laliberté M4, Lachaine J1
1University of Montreal, Montreal, QC, Canada, 2PeriPharm Inc., Montreal, QC, Canada, 3Maisonneuve-Rosemont Hospital, Montreal, QC, Canada, 4Abbvie Inc., Montreal, QC, Canada

PHS60
B22
RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH THE INVESTIGATION OF PULMONARY NODULES IN QUEBEC, CANADA
Gouault Laliberté A1, Bergeron C2, Chalifour J3, Lafond C4, Lachaine J1
1University of Montreal, Montreal, QC, Canada, 2Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 3Hôpital régional de Saint-Jérôme, Saint-Jerome, QC, Canada, 4Hôpital du Sacré-Coeur de Montréal, Montreal, QC, Canada

PHS61
B23
FOLLOW-UP IMAGING AFTER NEPHRECTOMY IN CANADA: UROLOGISTS’ COMPLIANCE WITH GUIDELINES AND COST OF SURVEILLANCE
Dragomir A, Prévost N, Aprikian A, Tanguay S
McGill University Health Centre, Montreal, QC, Canada

PHS62
B24
COST ANALYSIS OF THE MOLECULAR SCREENING AND GENETIC DIAGNOSIS OF LYNCH SYNDROME IN CATALONIA (SPAIN)
Corral J1, Pineda M2, Jiménez C2, González S2, Navarro M2, Brunet J3, Lázaro C2, Capellà G2
1Department of Health - Generalitat de Catalunya, Hospitalet de Llobregat, Spain, 2Institut Català d’Oncologia-IDIBELL, Hospitalet de Llobregat, Spain, 3Institut Català d’Oncologia-IDIBIG, Girona, Spain

PHS63
B25
ANALYSIS OF THE INDICATOR "THRESHOLD WILLINGNESS TO PAY" IN LEUKEMIA PATIENTS BY GENDER ACCORDING TO THE SURVEY IN UKRAINE
Panfilova A, Korzh Y, Tsurikova O, Zaritskaya G
National University of Pharmacy, Kharkov, Ukraine

HEALTH SERVICES - Patient-Reported Outcomes & Patient Preference Studies
PHS64
B26
EVALUATION OF ADHERENCE TO MANAGEMENT GUIDELINES OF ASTHMATIC PATIENTS IN GREECE AND MEASURES TO IMPLEMENT TO ACHIEVE ASTHMA CONTROL
Kaitelidou D1, Katostaras T2, Konstantakopoulou O3, Angelopoulos G3, Siskou O3, Tsioni E3, Gaga M4, Galanis P3, Theodorou M1, Charalambous G5, Lemonidou C2
1Open University of Cyprus, Latsia, Nicosia, Cyprus, 2National and Kapodistrian University of Athens, Athens, Greece, 3Center for Health Services Management and Evaluation, National and Kapodistrian University of Athens, Athens, Greece, 4Athens Chest Hospital, ATHENS, Greece, 5Hippocratio Hospital of Athens, ATHENS, Greece

PHS65
B27
IMPACT OF COMORBIDITIES ON MEDICATION ADHERENCE IN HYPERTENSIVE PATIENTS
Arukala P
St.Peter's Institute of Pharmaceutical Sciences, Hanamkonda, India

PHS66
B28
PATIENT COUNSELING BY A SPECIALTY PHARMACIST INCREASES PAIN MEDICATION ADHERENCE AND PERSISTENCY
Burruss RA1, Olson T1, Garofalo DF1, Arikian V2, Oleru K1, Malik F1, Wood A1, Traurig T3, Feinberg BA1
1Cardinal Health, Dublin, OH, USA, 2State University of New York Downstate Medical Center, Brooklyn, NY, USA, 3OncoSource Rx, Columbia, MD, USA

PHS67
B29
• ANALYSIS OF THE FACTORS AFFECTING PARENTS’ MEDICATION ADHERENCE IN ASTHMATIC CHILDREN USING EXPECTATION CONFIRMATION THEORY
Almogbel Y1, Abughosh S1, Essien EJ1, Sansgiry S2, Fleming ML1, Sansgiry SS1
1University of Houston, Houston, TX, USA, 2Michael E. DeBakey VA Medical Center, Houston, TX, USA

PHS68
B30
ONE-YEAR PATIENT-REPORTED PERSISTENCE TO ANTIRESORPTIVE TREATMENT IN A FRACTURE LIAISON SERVICE: THE LUCKY BONE™ PROGRAM
Senay A1, Delisle J2, Raynauld J3, Banica A2, Troyanov Y2, Beaumont P2, Giroux M4, Jodoin A2, Laflamme Y2, Leduc S2, MacThiong J2, Malo M2, Maurais G2, Nguyen H4, Parent S2, Ranger P2, Rouleau D2, Perreault S1, Fernandes JC2
1Université de Montréal, Montreal, QC, Canada, 2Hôpital du Sacré-Coeur de Montréal, Montreal, QC, Canada, 3Institut de rhumatologie de Montréal, Montreal, QC, Canada, 4Hôpital Jean-Talon, Montreal, QC, Canada

PHS69
B31
COMPARISON OF THREE GENERIC UTILITY INSTRUMENTS IN PATIENTS WITH RENAL DISEASE
Ruiz MA1, Bogeat J2, Muñoz V1, Monroy M1, Julian JC2
1Universidad Autónoma de Madrid, Madrid, Spain, 2ALCER, Madrid, Spain

PHS70
B32
IMPACT OF ANIMAL TESTING ON MENTAL HEALTH OF RESEARCHERS
Kang M, Han A, Lim K, Bae S
Ewha Womans University, Seoul, South Korea

PHS71
B33
A REAL-WORLD OUTCOME RESEARCH STUDY ON QUALITY OF LIFE, WORK PRODUCTIVITY AND HEALTHCARE RESOURCE UTILIZATION IN METASTATIC BREAST CANCER FOR PATIENTS AND CAREGIVERS
Lambert-Obry V1, Gouault Laliberté A2, Castonguay A2, Zanotti G3, Banerjee R4, Mates M5, Lemieux J6, Chabot P7, Prady C8, Couture F9, Lachaine J1
1University of Montreal, Montreal, QC, Canada, 2PeriPharm Inc., Montreal, QC, Canada, 3Pfizer, Inc., New York, NY, USA, 4Pfizer Canada, Kirkland, QC, Canada, 5Kingston General Hospital Research Institute, Kingston, ON, Canada, 6Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada, 7Maisonneuve-Rosemont Hospital, Montreal, QC, Canada, 8Centre intégré de cancérologie de la Montérégie - Centre intégré de santé et de services sociaux de la Montérégie-Centre, Greenfield Park, QC, Canada, 9Centre de santé et de services sociaux Alphonse-Desjardins, Centre hospitalier affilié Universitaire de Lévis, Levis, QC, Canada

PHS72
B34
EVALUATING THE EXPERIENTIAL QUALITY OF OLDER PEOPLE'S COMMUNITY CARE: A CONCEPT MAPPING APPROACH TO INSTRUMENT DESIGN
Wilberforce M1, Challis D1, Davies L1, Roberts C1, Kelly MP2
1University of Manchester, Manchester, UK, 2University of Cambridge, Cambridge, UK

PHS73
B35
USING ADVANCED MODELING TO IDENTIFY THE FACTOR STRUCTURE OF THE IMPROVED HEALTH ACTIVITIES QUESTIONNAIRE
Kudel I1, Winget M1, Vietri J2
1Kantar Health, New York, NY, USA, 2Kantar Health, Horsham, PA, USA

PHS74
B36
HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A SPANISH STUDY BASED ON PATIENT REPORTS
Fernández-Llanio-Comella N1, San-Martín-Álvarez A2, Vivas-Consuelo D3, Jordán-Alfonso A3, Román Ivorra JA1, Vela-Casasempere P2, Saurí-Ferrer MI4
1Conselleria de Sanidad Universal y Salud Pública, Valencia, Spain, 2Conselleria de Sanidad Universal y Salud Pública, Alicante, Spain, 3Universitat Politècnica de València (UPV), Valencia, Spain, 4General Directorate for Pharmacy and Healthcare Products, Valencia, Spain

PHS75
B37
PESSOA STUDY – EVALUATING THE BURDEN OF PSORIASIS IN PORTUGAL FROM THE PATIENTS’ PERSPECTIVE (A PATIENT REPORTED OUTCOMES ANALYSIS)
Moital I1, Carrasco J1, Adegas P1, Cabrita J2, Oliveira Martins S2
1Novartis Farma Portugal, Porto Salvo, Portugal, 2Faculty of Pharmacy UL, Lisbon, Portugal

PHS76
B38
ECONOMIC AND HUMANISTIC BURDEN OF CHRONIC SPONTANEOUS URTICARIA IN BRAZIL: IMPACT ON WORK PRODUCTIVITY, RESOURCE UTILIZATION AND QUALITY OF LIFE
Balp M1, Lopes N2, Tian H3, Vietri J4, Ensina LF5
1Novartis Pharma AG, Basel, Switzerland, 2Novartis Brazil, Sao Paulo, Brazil, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 4Kantar Health, Horsham, PA, USA, 5Federal University of São Paulo, São Paulo, SP, Brazil

PHS77
C1
THE ASSOCIATION BETWEEN PARENTING STRESS AND THE CHILD’S QUALITY OF LIFE AMONG PARENTS OF ASTHMATIC CHILDREN
Sansgiry SS, Almogbel Y
University of Houston, Houston, TX, USA

PHS78
C2
THE EQ-5D-5L INSTRUMENT DEMONTRATES BETTER PERFORMANCE COMPARED WITH THE EQ-5D-3L IN PSORIATIC PATIENTS
Yfantopoulos I, Chantzaras A, Kontodimas S
University of Athens, Athens, Greece

PHS79
C3
IDENTIFICATION OF ADVERSE EVENTS IN CORONARY ARTERY DISEASE PATIENTS BASED ON HEALTH-RELATED QUALITY OF LIFE OUTCOME DATA
Heiskanen J1, Tolppanen A2, Martikainen JA2, Hartikainen J1, Miettinen H1, Hippeläinen M1, Roine RP2
1Kuopio University Hospital, Kuopio, Finland, 2University of Eastern Finland, Kuopio, Finland

PHS80
C4
THE IMPACT OF PSORIASIS VULGARIS ON HEALTH RELATED QUALITY OF LIFE IN GREECE
Yfantopoulos I, Chantzaras A, Kontodimas S
University of Athens, Athens, Greece

PHS81
C5
THE EFFECT OF ACNE ON THE QUALITY OF LIFE IN BULGARIA - PILOT STUDY
Petkova V1, Husain S1, Lambov N1, Andreevska K2, Grekova D2
1Medical University-Sofia, Faculty of Pharmacy, Sofia, Bulgaria, 2Medical University - Plovdiv, Plovdiv, Bulgaria

PHS82
C6
THE PARETO PRINCIPLE ("80-20 RULE") IN HEALTHCARE SERVICES IN GREECE
Naoum V1, Kyriopoulos D2, Charonis A1, Athanasakis K1, Kyriopoulos J1
1National School of Public Health, Athens, Greece, 2London School of Economics and Political Science, London, UK

HEALTH SERVICES - Health Care Use & Policy Studies
PHS83
C7
CT AND MRI UNITS IN CYPRUS: A MARKET ANALYSIS
Theodorou M1, Kaitelidou D1, Kantaris M2, Angelopoulos G3, Lemonidou C3
1Open University of Cyprus, Latsia, Nicosia, Cyprus, 2OPEN UNIVERSITY CYPRUS, NICOSIA, Cyprus, 3National and Kapodistrian University of Athens, Athens, Greece

PHS84
C8
TWO MODELS OF PUBLIC EDUCATIONS, STORYTELLING & ANIMATED MOVIES: CONS AND PROS
Mohammadhosseini N1, Abdolghaffari AH2, Soleymani F1, Taheri F3, Aghamohammadzadeh S3, Houshyar M4, Kazemi M5, Afrazi S5
1National Committee on Rational Drug use, Tehran, Iran, 2Tehran University of Medical Sciences, Tehran, Iran, 3Minitry of Health, tehran, Iran, 4Department of health and wellness general education of Bushehr Provience, Bushehr, Iran (Islamic Republic of), 5Bushehr University of Medical Sciences, Bushehr, Iran (Islamic Republic of)

PHS85
C9
THE UTILIZATION OF HEALTH SERVICES BY THE OLDER EUROPEANS: AN ECONOMETRIC ANALYSIS
Srakar A1, Hren R2, Prevolnik Rupel V1
1Institute for Economic Research, Ljubljana, Slovenia, 2University of Ljubljana, Ljubljana, Slovenia

PHS86
C10
EXPERIENCES AND ATTITUDES RELATED TO SCREENING OF PATIENTS ATTENDED ON A COLORECTAL SCREENING PILOT PROGRAM IN HUNGARY
Horváthné Kívés Z1, Vajda R1, Kovács A2, Budai A2, Párkányi P2, Danku N1, Boncz I1
1University of Pécs, Pécs, Hungary, 2National Public Health and Medical Officers Service (ÁNTSZ), Budapest, Hungary

PHS87
C11
KNOWLEDGE AND PARTICIPATION RATE ON CERVICAL CANCER SCREENING AMONG ROMANY MINORITY POPULATION
Vajda R1, Novákné Szabó S1, Horváthné Kívés Z1, Boncz I1, Danku N1, Gyuró M1, Pakai A2
1University of Pécs, Pécs, Hungary, 2University of Pécs, Zalaegerszeg, Hungary

PHS88
C12
CANCER PREVENTION: KNOWLEDGE AND ATTITUDES AMONG HEALTHCARE PROFESSIONALS
Vajda R1, Futóné Gura S1, Pakai A2, Horváthné Kívés Z1, Gyuró M1, Danku N1, Boncz I1
1University of Pécs, Pécs, Hungary, 2University of Pécs, Zalaegerszeg, Hungary

PHS89
C13
ATTITUDE AND WILLINGNESS TO PARTICIPATE ON SCREENING OF FIRST-DEGREE RELATIVES OF COLORECTAL CANCER PATIENTS
Hajdú J1, Vajda R2, Danku N2, Boncz I2, Horváthné Kívés Z2
1Baranya County Government Office, Dombóvár, Hungary, 2University of Pécs, Pécs, Hungary

PHS90
C14
ASSESSMENT OF A PILOT PROGRAM ON CERVICAL CANCER SCREENING CARRIED OUT BY HEALTH VISITORS IN HUNGARY
Vajda R1, Horváthné Kívés Z1, Kovács A2, Budai A2, Árváné Egri C2, Danku N1, Boncz I1
1University of Pécs, Pécs, Hungary, 2National Public Health and Medical Officers Service (ÁNTSZ), Budapest, Hungary

PHS91
C15
HIGH DEMAND FOR POST-EXPOSURE PROPHYLAXIS (PEP) FOR CONSENSUAL SEX EXPOSURE SUGGESTS A NEED FOR PRE-EXPOSURE PROPHYLAXIS (PREP) IN UGANDA
Musomba R, Futumu S, Nabongo P, Mackline H, Nabaggala SM, Semakula E, Castelnuovo B, Mohammed L
Infectious Diseases Institute, College of Health Sciences Makerere University, Kampala, Uganda

PHS92
C16
EFFECTIVENESS OF IDENTIFYING A CANCER PATIENT IN THE HOSPITAL SECTOR IN NORTHERN-NORWAY - ANALYSES BASED ON REGIONAL PERFORMANCE DATABASE
Totth A1, Skjemstad ES1, Hjemås PC1, Storjord T2, Norum J3, Sundset R1
1Northern Norway Regional Health Authority Trust, Bodø, Norway, 2University Hospital of North Norway, Tromsø, Norway, 3UiT-The Arctic University of Norway, Tromsø, Norway

PHS93
C17
DRG APPROPRIATENESS ANALYSIS USING ACTIVITY-BASED-COSTING METHOD : A CASE OF BURN DIAGNOSIS
Jerabkova S1, Jánošíková O2
1University of Economics, Prague, Prague, Czech Republic, 2Czech Technical University in Prague, Kladno, Czech Republic

PHS94
C18
MARKET SHARE OF ADDICTOLOGY ACCORDING TO THE SYSTEM OF DIAGNOSIS RELATED GROUPS (DRGS) IN HUNGARY
Danku N, Ágoston I, Endrei D, Horváthné Kívés Z, Vajda R, Molics B, Boncz I
University of Pécs, Pécs, Hungary

PHS95
C19
UNDERSTANDING THE ROLE OF DERMATOLOGISTS AND ONCOLOGISTS IN MELANOMA TREATMENT IN FRANCE AND THE UK
Mpima S, Casey V, Nasuti P
IMS HEALTH UK, London, UK

PHS96
C20
THE ORGANISATIONAL ANALYSIS OF “PATIENT DIAGNOSTIC THERAPEUTIC PATHWAY” FOR PATIENTS WITH GASTRIC CANCER IN 5 CENTRES OF THE VENETO REGION (ITALY)
Palla I, Cannizzo S, Turchetti G
Scuola Superiore Sant'Anna, Pisa, Italy

PHS97
C21
DIABETES SELF-MANAGEMENT: PHARMACY PERSPECTIVE
Petkova V1, Kolev N1, Dimitrov M2
1Medical University-Sofia, Faculty of Pharmacy, Sofia, Bulgaria, 2Medical University - Sofia, Sofia, Bulgaria

PHS98
C22
ECONOMIC CONSEQUENCES OF THE DETERMINALISTIC RELATION BETWEEN LABORATORY TESTS INDICATION AND ANTIBIOTIC PRESCRIPTION
Haramiova Z, Stasko M, Minarikova D, Malovecka I, Foltan V
Comenius University, Faculty of Pharmacy, Bratislava, Slovakia

PHS99
C23
PATIENT CENTRICITY – PATIENT RELATED PROGRAMS IN THE GERMAN HEALTHCARE ENVIRONMENT
Schwarz R, Freiberg M, Sprick J, Thiele J
Quintiles Commercial Germany GmbH, Mannheim, Germany

PHS100
C24
BURDEN OF DISEASE AND MANAGEMENT OF MESOTHELIOMA IN FRANCE: A NATIONAL COHORT ANALYSIS
Tournier C1, Blein C2, Monnet I3, Andujar P3, Vainchtock A2, Scherpereel A4, Pairon JC3, Chouaid C5
1HEVA, LYON, France, 2HEVA, Lyon, France, 3CHI CRETEIL, CRETEIL, France, 4CHU Lille, Lille, France, 5Centre Hospitalier Intercommunal, DHU-ATVB, Département de Pneumologie et Pathologie Professionnelle, Créteil, France

PHS101
C25
RESULTS FROM AN ON-SITE HEALTHCARE PROVIDER SURVEY ON PERCEPTIONS OF TYPE 2 DIABETES TREATMENT
Taylor D, Croce S, Sjostedt P
Institute for Evidence Based Medicine, New Hope, PA, USA

PHS102
C26
EVALUATING EFFECTIVENESS AND PERSISTENCY OF A PHARMACIST-LED DISEASE MANAGEMENT PROGRAM
Zhou Z, Feng Z, Joyce G
University of Southern California, Los Angeles, CA, USA

PHS103
C27
ORAL AND GENERAL HEALTH RELATED QUALITY OF LIFE IN TIMES OF CRISIS IN GREECE
Yfantopoulos I, Chantzaras A, Yfantopoulos P
University of Athens, Athens, Greece

PHS104
C28
THE ROLE OF PHARMACY INFORMATION SYSTEMS, FORMULARY ARRANGMNET,SUPPLAY CHAIN AND DISTRBUTION SYSTEM TO IMPROVE PATIENTS' ACCESS TO PRESCRIPTION DRUG IN SAUDI HOSPITALS: A CROSS-SECTIONAL DESCRIPTIVE STUDY
Alsultan M1, Alkelya M2
1University of Dammam, Dammam, Saudi Arabia, 2King Abdullah International Medical Research Center (KAIMRC), Ryiadh, Saudi Arabia

PHS105
C29
IMPACT OF STATE MANDATED QUERIES OF THE PRESCRIPTION DRUG MONITORING PROGRAMS ON OPIOID AND NON-OPIOID DRUG RELATED ADVERSE EFFECTS: A DIFFERENCE IN DIFFERENCE APPROACH
Hayes CJ, Chopra D, Shah AB, Martin BC
University of Arkansas for Medical Sciences College of Pharmacy, Little Rock, AR, USA

PHS106
C30
UNDERSTANDING RACIAL AND ETHNIC DIFFERENCES IN END OF LIFE CARE FOR HOSPITALIZED PATIENTS
Johnson TJ1, O'Mahony S2, Levine S3, Walton SM4, Baron A5
1Rush University, Chicago, IL, USA, 2Rush University Medical Center, Chicago, IL, USA, 3University of Chicago Medicine, Chicago, IL, USA, 4University of Illinois at Chicago, Chicago, IL, USA, 5University of Chicago, Chicago, IL, USA

PHS107
C31
DELAYS IN BREAST CANCER DIAGNOSIS AND INITIATION OF TREATMENT: IMPLEMENTING THE PATHWAYS TO TREATMENT MODEL IN THE GREEK SETTING
Tsiantou V1, Karampli E1, Zavras D1, Skroumpelos A2, Athanasakis K1, Mylona K2, Pavi E1, Kyriopoulos J1
1National School of Public Health, Athens, Greece, 2Roche (Hellas) S.A., Athens, Greece

PHS108
C32
EFFECTIVE USE OF SHORT-TERM HEALTHCARE BY IMMIGRANTS IN CHILE: LINKING EVIDENCE TO POLICY FOR UNIVERSAL COVERAGE
Cabieses B1, Oyarte M1, Pedrero V1, Bernales M1, Espinoza MA2
1Universidad del Desarrollo, Santiago, Chile, 2Pontificia Universidad Catolica de Chile, Santiago, Chile

PHS109
C33
HELPING DECISION-MAKERS VISUALIZE INEQUITIES IN HEALTH IMPACT ASSESSMENT: LINKED ELECTRONIC RECORDS, MORTALITY AND REGIONAL DISPARITIES IN PORTUGAL
Bacelar-Nicolau L1, Rodrigues T2, Fernandes E2, Lobo MF3, Nisa C3, Azzone V4, Teixeira-Pinto A5, Rocha-Gonçalves FN6, Azevedo LF3, Freitas A3, Normand ST4, Costa-Pereira A3, Pereira Miguel J1
1Faculty of Medicine &ISAMB, University of Lisbon, Lisbon, Portugal, 2Faculty of Medicine, University of Lisbon, Lisbon, Portugal, 3Faculty of Medicine, University of Porto, Porto, Portugal, 4Harvard Medical School, Boston, MA, USA, 5The University of Sydney, Sydney, Australia, 6IPO Porto, Porto, Portugal

PHS110
C34
EFFECTIVE USE OF LONG-TERM HEALTHCARE IN CHILE: ARE INTERNATIONAL MIGRANTS AT DISADVANTAGE OF UNIVERSAL HEALTH COVERAGE
Oyarte M1, Cabieses B1, Pedrero V1, MacIntyre AM1, Espinoza MA2
1Universidad del Desarrollo, Santiago, Chile, 2Pontificia Universidad Catolica de Chile, Santiago, Chile

PHS111
C35
THE IMPACT OF COMMUNITY PHARMACIES (CP) ON REGIONAL EQUITY IN THE ACCESS TO THE PORTUGUESE NEEDLE AND EXCHANGE PROGRAMME (NEP)
Gouveia M1, Borges M2, Fiorentino F2, Jesus G2, Guerreiro JP3, Cary M3, Costa S3, Vaz Carneiro A2
1Católica Lisbon School of Business and Economics, Lisbon, Portugal, 2Center for Evidence Based Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal, 3Center for Health Evaluation & Research, Lisbon, Portugal

PHS112
C36
FUTURE DISPARITIES BETWEEN DEMAND AND SUPPLY OF TERTIARY EMERGENCY CARE IN REGIONS AFFECTED BY THE GREAT EAST JAPAN EARTHQUAKE
Sakai M1, Ohta S2, Okuchi K3, Yokota J4, Shimada J5, Takahashi Y1, Nakayama T1
1Kyoto University School of Public Health, Kyoto, Japan, 2Health Informatics and Management Professionals (HIMAP) General Association, Tokyo, Japan, 3Nara Medical University, Nara, Japan, 4Sakai City Medical Center, Osaka, Japan, 5Fukushima Medical University, Fukushima, Japan

PHS113
C37
SURVIVAL AND DEATH RISK OF PATIENTS WITH PROSTATE CANCER TREATED IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mendes Braga S1, Souza MC2, Oliveira RR3, Andrade EI3, Acurcio Fd4, Cherchiglia ML3
1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 2Instituto Nacional do Câncer, Rio de Janeiro, Brazil, 3Federal University of Minas Gerais, Belo Horizonte, Brazil, 4College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil

PHS114
C38
WITHDRAWN

PHS115
D1
FACTORS INFLUENCING DOOR-TO-DOCTOR TIME IN AN EMERGENCY DEPARTMENT: DISCRETE EVENT SIMULATION MODEL
Ribeiro RA1, Baungratz EN2, Vaccaro G2, Schmitz PS3, Fernandes AK3, Colpani V4, Falavigna M3
1IMED - Faculdade Meridional and Fundação IMED, Passo Fundo, Brazil, 2UNISINOS, São Leopoldo, Brazil, 3Hospital Moinhos de Vento, Porto Alegre, Brazil, 4IMED - Faculdade Meridional, Passo Fundo, Brazil

PHS116
D2
INTERNATIONAL PEDIATRIC HOSPITAL PATIENT OUTCOMES
Johnson TJ1, Goudarzi R1, Hohmann SF2, Garman AN1, Cieslak P3, Ubhayakar S1
1Rush University, Chicago, IL, USA, 2Vizient, Inc., Chicago, IL, USA, 3Rush University Medical Center, Chicago, IL, USA

PHS117
D3
INCREASED USE OF EFFECTIVE NON-CANCER DRUGS FOLLOWING REMOVAL OF BENEFIT CAPS AMONG CANCER PATIENTS IN MEDICAID: A QUASI-EXPERIMENTAL STUDY
Adams AS1, Madden JM2, Zhang F3, Lu CY3, Ross-Degnan D3, Soumerai SB3, Lee A4, Gilden D4, Chawla N1, Griggs JJ5
1Kaiser Permanente Division of Research, Oakland, CA, USA, 2Northeastern University, Boston, CA, USA, 3Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, USA, 4Jen Associates, Inc, Cambridge, MA, USA, 5University of Michigan, School of Public Health, Ann Arbor, MI, USA

PHS118
D4
COST OF HEALTHCARE AMONG METASTATIC LUNG CANCER PATIENTS RECEIVING CHEMOTHERAPY
Bhandari NR, Kathe NJ, Martin BC
University of Arkansas for Medical Sciences College of Pharmacy, Little Rock, AR, USA

PHS119
WITHDRAWN

PHS120
D5
CANCER CONCERNS FROM UNITED STATES MEDICAL AND PHARMACY DIRECTORS 2016
Brook RA1, McManama SH2, Sax MJ2, Smeeding JE3
1The JeSTARx Group & NPRT, Newfoundland, NJ, USA, 2The Pharmacy Group, Glastonbury, CT, USA, 3The TPG-NPRT & JeSTARx, Glastonbury, CT, USA

PHS121
D6
COST IMPLICATIONS OF ADAPTING THE INVESTIGATION AND DIAGNOSIS PATHWAY OF INFERTILTY PATIENTS IN A UK NHS SETTING
Davies S1, Umranikar A1, Huggins T2, Gauthier A3, Harty GT2
1Salisbury NHS Foundation Trust, Salisbury, UK, 2Merck Serono, London, UK, 3Amaris, London, UK

PHS122
D7
THE PATIENT JOURNEY AFTER A DIAGNOSIS OF EARLY/LOCALLY ADVANCED BREAST CA IN GREECE AND CHOICE OF PROVIDER
Karampli E1, Tsiantou V1, Skroumpelos A2, Mylona K2, Athanasakis K1, Zavras D1, Pavi E1, Kyriopoulos J1
1National School of Public Health, Athens, Greece, 2Roche (Hellas) S.A., Athens, Greece

PHS123
D8
ECONOMIC BURDEN OF MEDICAL TRANSPORTS IN FRANCE OVER THE YEAR 2014
Feyt C, Blein C, Vainchtock A
HEVA, Lyon, France

PHS124
D9
SECOND MEDICAL OPINION: UTILIZATION RATES AND CHARACTERISTICS OF SEEKERS IN A GENERAL POPULATION
Shmueli L1, Shmueli E2, Pliskin JS1, Balicer RD3, Davidovitch N1, Hekselman I4, Greenfield G5
1Ben-Gurion University of the Negev, Beer-Sheva, Israel, 2Tel-Aviv University, Tel-Aviv, Israel, 3Clalit Research Institute, Tel Aviv, Israel, 4Clalit Mushlam Health Insurance, Bnei Brak, Israel, 5Imperial College London, London, UK

PHS125
D10
THE IMPACT OF THE ECONOMIC CRISIS ON THE INCIDENCE AND INTENSITY OF CATASTROPHIC HEALTH PAYMENTS IN GREECE
Yfantopoulos I1, Chantzars A1, Ollandezos M2
1University of Athens, Athens, Greece, 2Panhellenic Union of Pharmaceutical Industry, Athens, Greece

PHS126
D11
COST-EFFECTIVENESS ANALYSIS OF AN AUTOMATED MEDICATION SYSTEM IMPLEMENTED IN A DANISH HOSPITAL SETTING
Risør BW1, Lisby M2, Sørensen J1
1University of Southern Denmark, Odense, Denmark, 2Aarhus University Hospital, Aarhus, Denmark

PHS127
D12
ECONOMIC BURDEN OF VARICELLA IN CHILDREN IN POLAND, 2011-2015
Wysocki J1, Malecka I1, Stryczynska-Kazubska J1, Rampakakis E2, Yang K3, Kuter BJ3, Wolfson LJ3
1Poznan University of Medical Sciences, Poznan, Poland, 2JSS Medical Research, Saint-Laurent, QC, Canada, 3Merck & Co., Inc., Kenilworth, NJ, USA

PHS128
D13
BUDGET IMPACT ANALYSIS OF INTRODUCING PHARMACIST-MANAGED WARFARIN SERVICE IN THE REPUBLIC OF SERBIA
Stojkovic T, Bogavac-Stanojevic N, Marinkovic V, Lakic D
University of Belgrade-Faculty of Pharmacy, Belgrade, Serbia

PHS129
D14
EVALUATION OF THE ECONOMIC IMPACT OF FERRIC CARBOXYMALTOSE USE FOR THE FRENCH NATIONAL HEALTH INSURANCE AND THE FRENCH HOSPITALS ORGANIZATION
Champs F1, Augry R1, Bourguignon S1, Degrassat-Théas A2, Paubel P3
1STRATEGIQUE SANTE, Evry, France, 2Law and health economics department, Faculty of Pharmacy), Paris, France, 3General Agency of Equipment and Health Products (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

PHS130
D15
SEVERE SEPSIS IN ADULTS: IMPACT OF DIAGNOSTIC CODING ON HOSPITAL RESOURCE UTILIZATION
Bouza C, Lopez-Cuadrado T, Amate-Blanco JM
Instituto de Salud Carlos III, Madrid, Spain

PHS131
D16
AVOIDABLE HOSPITALIZATIONS THROUGH EFFECTIVE PRIMARY CARE AT A PEDIATRIC HOSPITAL IN THE COLOMBIAN CARIBBEAN
Alvis L1, Castillo I1, Vivas-Consuelo D2, Alvis Guzman N3, Orozco J4
1Universidad de Cartagena, Cartagena de Indias, Colombia, 2Uni, Valencia, Colombia, 3Universidad de Cartagena. Centro de Investigación y Docencia. Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 4COOSALUD EPS, Cartagena de Indias, Colombia

PHS132
D17
SOCIAL AND ECONOMIC VALUE OF PORTUGUESE COMMUNITY PHARMACIES IN PUBLIC HEALTH
Félix J1, Ferreira D1, Afonso-Silva M1, Gomes M1, Ferreira C1, Vandewalle B1, Marques S1, Mota M1, Costa S2, Cary M2, Teixeira I2, Paulino E3, Macedo B3, Barbosa M4
1Exigo Consultores, Lisboa, Portugal, 2Center for Health Evaluation & Research, Lisbon, Portugal, 3Portuguese Pharmaceutical Society, Lisbon, Portugal, 44Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal

PHS133
D18
IMPACT OF CONTINUITY OF CARE ON CARE AND COSTS FOR CHRONIC DISEASE
Cheng J, Ku H
Chang Gung University, Tao-Yuan, Taiwan

PHS134
D19
ECONOMIC BURDEN OF DISEASES IN POLAND
Lesniowska J
Kozminski University, Warsaw, Poland

PHS135
D20
ECONOMIC EVALUATION OF THE PORTUGUESE NEEDLE EXCHANGE PROGRAMME IN COMMUNITY PHARMACIES (NEP-CP)
Borges M1, Gouveia M2, Fiorentino F1, Jesus G1, Cary M3, Guerreiro JP3, Costa S3, Vaz Carneiro A1
1Center for Evidence Based Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal, 2Católica Lisbon School of Business and Economics, Lisbon, Portugal, 3Center for Health Evaluation & Research, Lisbon, Portugal

PHS136
D21
THE ECONOMIC IMPACT OF TOBACCO SMOKING IN THE LATIN-AMERICAN HEALTHCARE SYSTEMS: A STUDY CONDUCTED IN SEVEN COUNTRIES AND ITS EXTRAPOLATION AT THE REGIONAL LEVEL
Alcaraz A, Pichon-Riviere A, Bardach A, Augustovski F
Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina

PHS137
D22
ENGLISH CCG FORMULARIES: RESOURCES AND PRIORITIES
Murphy E
Cogora, London, UK

PHS138
D23
ECONOMIC BENEFITS OF THE BABY FRIENDLY HOSPITAL INITIATIVE IN A SECOND CARE HOSPITAL IN MÉXICO
May H
Quintana Roo University, Chetumal, Mexico

PHS139
D24
THE HEALTH ECONOMICS ANALYSIS OF UNQUALIFIED VENOUS BLOOD SAMPLES IN THE CHINESE TERTIARY REFERRAL HOSPITAL
Cong Y
General Hospital Of People's Liberation Army, Beijing, China

PHS140
D25
THE RELATIONSHIP BETWEEN ANTENATAL CARE AND HEALTH FACILITY DELIVERY
Singh S, Rana P, Gollala M, Singh R, Rai MK
Tata Consultancy Services, Mumbai, India

PHS141
D26
THE INCREASING IMPORTANCE OF A CONTINENCE NURSE SPECIALIST TO IMPROVE OUTCOMES AND SAVE COSTS OF URINARY INCONTINENCE CARE: AN ANALYSIS OF FUTURE POLICY SCENARIOS
Los J, Corro-Ramos I, Franken M, Al M
Erasmus University Rotterdam, Rotterdam, The Netherlands

PHS142
D27
MULTIPLE SCLEROSIS: REAL-WORLD HEALTHCARE COSTS IN A LARGE US HEALTH PLAN
Sanchirico M1, Ma I1, Caldwell A2, Mudumby P2, Hashemi L1, Dufour R2
1Sanofi Genzyme, Cambridge, MA, USA, 2Comprehensive Health Insights, Louisville, KY, USA

PHS143
D28
FACTORS AFFECTING PROLONGED LENGTH OF STAY IN PATENTS WITH MOOD DISORDERS
Shinjo D1, Tachimori H2, Sakurai K3, Fushimi K4
1The University of Tokyo Hospital, Tokyo, Japan, 2National Center of Neurology and Psychiatry, Tokyo, Japan, 3The University of Tokyo, Tokyo, Japan, 4Tokyo Medical and Dental University Graduate School of Medicine, bunkyo-ku, Japan

PHS144
D29
IMPACT OF COMMUNITY CARE SUBSIDIES ON CARE USE OF ELDERLY PEOPLE
Rapp T
Harvard School of Public Health, Boston, MA, USA

PHS145
D30
HEALTH TECHNOLOGY ASSESSMENT CONSIDERATIONS OF THE PRIMARY CARE MODEL PROGRAMME
Nagyjánosi L1, Merész G2, Joó T1, Dózsa KM2
1University of Debrecen, Debrecen, Hungary, 2Semmelweis University, Budapest, Hungary

PHS146
D31
WHY SHOULD WE FOCUS ON A STRUCTURED MODEL OF SECURE DIGITAL EXCHANGES TO INCORPORATE NEW DOCUMENTS IN ELECTRONIC PATIENT RECORDS?
Perrier L1, Plantier M1, Farsi F2, Vandenbergh P3, Spacagna H2, Gomez F1, Biron P1, Durand T1
1Cancer Centre Léon Bérard, Lyon Cedex 08, France, 2Réseau Espace Santé Cancer Rhône-Alpes, Lyon, France, 3Agence régionale de santé (ARS) Auvergne-Rhône-Alpes, Lyon, France

PHS147
D32
ALCOHOLISM IN ITALY: AN INTRODUCTIVE ANALYSIS OF CONSUMPTION AND HOSPITALISATION TRENDS
Aiello A1, D'Ausilio A1, Latorre E1, Toumi M2
1Creativ Ceutical, Milano, Italy, 2Faculté de Médecine, Laboratoire de Santé Publique, Aix-Marseille Université, Université de la Méditerranée, Marseille, France

PHS148
D33
FRANCE-SPAIN COMPARISON OF HOSPITAL DELIVERY MODE BETWEEN 2006 AND 2014 ACCORDING COMORBIDITY PROFILES OF PATIENTS
Blein C1, Saitta B1, Antier PY2, Vainchtock A1
1HEVA, Lyon, France, 2SHAM, LYON Cedex 08, France

PHS149
D34
RISK OF MOTOR-VEHICLE ACCIDENTS INCREASES WITH MULTIMORBIDITY
Fortin Y1, Crispo JA1, McNair DS2, Cohen D3, Dahrouge S4, Mattison DR5, Krewski D5
1University of Ottawa, Ottawa, ON, Canada, 2Cerner Corporation, Kansas City, MO, USA, 3Canadian Institute for Health Information, Ottawa, ON, Canada, 4Bruyère Research Institute, Ottawa, ON, Canada, 5Risk Sciences International, Ottawa, ON, Canada

PHS150
D35
THE IMPACT OF PHARMACIST INTERVENTION ON MEDICATION ERRORS IN A TEACHING HOSPITAL QUETTA, PAKISTAN
Ahmed T1, Haq N1, Rehman M2, Nasim A1
1University of Balochistan, Quetta, Pakistan, 2Bolan Medical Complex Hopsital, Quetta, Pakistan

PHS151
D36
1) VALUE OF THE CLINICAL DECISION SUPPORT SYSTEM FOR ADVERSE DRUG EVENT PREVENTION: A COST-EFFECTIVENESS ANALYSIS AND COST-BENEFIT ANALYSIS
Kim HT1, Lee S2, Suh HS1
1Pusan National University, Busan, South Korea, 2Ajou University, Suwon-si, Gyeonggi-do, South Korea

PHS152
D37
BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF A COMPUTERIZED TEMPERATURE MANAGEMENT SYSTEM IN THE TREATMENT OF THERAPEUTIC HYPOTHERMIA IN GREECE
Maistreli S1, Kourlaba G2, Georgopoulos D3, Maniadakis N4
1Collaborative Center of Clinical Epidemiology and Outcomes Research (CLEO), Non-Profit Civil Partenrship, Athens, Greece, 2EVROSTON LP, Athens, Greece, 3Intensive Care Unit, University of Crete,, Crete, Greece, 4National School of Public Health, Athens, Greece

PHS153
D38
MANUFACTURERS’ AND PHARMACISTS’ SATISFACTION WITH DIFFERENT PHARMACEUTICAL DISTRIBUTION MODELS IN EUROPE
Walter E, Lazic-Peric A
Institute for Pharmaeconomic Research, Vienna, Austria

PHS154
E1
COMPREHENSIVE EVALUATION OF HEALTH CARE WORKERS PERCEPTIONS AND ATTITUDE ON PHARMACISTS INVOLVEMENT IN WARD ROUND IN THREE TERTIARY HOSPITALS IN SOUTH-EAST NIGERIA
Ogbonna BO
NNAMDI AZIKIWE UNIVERSITY, AWKA, ANAMBRA STATE, Nigeria

PHS155
E2
ASSESSMENT OF KNOWLEDGE OF URINARY TRACT INFECTION (UTI) AMONGST SCHOOL-GOING ADOLESCENT GIRLS
Bokolia R
K. B. Institute of Pharmaceutical Education & Research, AHMEDABAD, India

PHS156
E3
THE GERMAN PAIN PRACTICE REGISTRY – A NEW WAY TO USE REAL-TIME SAMPLED ROUTINE DATA FOR HEALTH-CARE RESEARCH
Ueberall MA1, Mueller-Schwefe GH2
1IFNAP, Nuernberg, Germany, 2German Pain Association, Goeppingen, Germany

PHS157
E4
A QUALITATIVE STUDY EXPLORING PERCEPTION AND ATTITUDES OF COMMUNITY PHARMACISTS ABOUT EXTENDED PHARMACY SERVICES IN LAHORE, PAKISTAN
Hashmi FK1, Hassali MA1, Saleem F1, Babar ZU2
1Universiti Sains Malaysia, Penang, Malaysia, 2The University of Auckland, Auckland, New Zealand

PHS158
E5
METHODOLOGY OF RESEARCH TO DETERMINE COST AND UTILITY OF PILOT ONE-STOP FERTILITY CLINIC VERSUS TRADITIONAL NHS FERTILITY INVESTIGATION PATHWAY
Batwala M1, Child T1, Harty GT2, Huggins T2
1Oxford University, Oxford, UK, 2Merck Serono, London, UK

PHS159
WITHDRAWN

PHS160
E6
FREQUENCY OF OCCURANCE OF MYOCARDIAL INFARCTION IN HUNGARY BETWEEN 2004-2012
Gresz M1, Endrei D2, Csákvári T3, Danku N2, Sebestyén A4, Horváth L2, Boncz I2
1National Healthcare Service Center, Budapest, Hungary, 2University of Pécs, Pécs, Hungary, 3University of Pécs, Zalaegerszeg, Hungary, 4National Health Insurance Fund Administration, Pécs, Hungary

PHS161
E7
DETERMINANTS OF THE IMPACT OF THE ECONOMIC CRISIS ON GENERAL AND ORAL HEALTH IN GREATER ATHENS AREA GREECE
Yfantopoulos I, Chantzaras A, Yfantopoulos P
University of Athens, Athens, Greece

PHS162
E8
A QUALITATIVE STUDY EVALUATING THE ATTITUDE AND PERCEPTION OF PHYSICIAN AND PHARMACIST TOWARDS PHARMACOVIGILANCE IN ABBOTTABAD, PAKISTAN
Syed A1, Azhar S1, Jamshed S2, Saeed H1, Saeed N1, Hussain SS3
1Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan, 2International Islamic University, Malaysia, Kuantan, Malaysia, 3King Edward VI Camp Hill, Birmingham, UK

PHS163
E9
ASSESSMENT OF KNOWLEDGE, ATTITUDE AND BARRIERS TOWARDS ADRS REPORTING AMONG HEALTHCARE PROFESSIONALS OF ABBOTTABAD, PAKISTAN
Syed A1, Jamshed S2, Azhar S1, Rasheed HM1, Bukhari A1, Khalid S1, Batul SS3
1Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan, 2International Islamic University, Malaysia, Kuantan, Malaysia, 3King Edward VI Camp Hill for Girls, Birmingham, UK

PHS164
E10
KNOWLEDGE, ATTITUDES AND PRACTICES OF CERVICAL CANCER SCREENING AMONG WOMEN ATTENDING A CHILDHOOD IMMUNIZATION CLINIC IN UGANDA
Nuwasiima A1, Navvuga P1, Nuwamanya E1, Lubinga S2, Babigumira J2
1Global Health Economics Limited, Kampala, Uganda, 2University of Washington, Seattle, WA, USA

PHS165
E11
THE CLINICAL, FUNCTIONAL AND ECONOMIC BENEFITS OF PHYSICAL REHABILITATION: A SYSTEMATIC REVIEW
Maistreli S1, Gourzoulidis G2, Vellopoulou K3, Kourlaba G3, Maniadakis N4
1Collaborative Center of Clinical Epidemiology and Outcomes Research (CLEO), Non-Profit Civil Partenrship, Athens, Greece, 2EVROSTON, Athens, Greece, 3EVROSTON LP, Athens, Greece, 4National School of Public Health, Athens, Greece

PHS166
E12
ECONOMIC BURDEN OF STROKE: A SYSTEMATIC REVIEW ON POST-STROKE CARE
Rajsic S1, Gothe H2, Borba HH3, Vujicic J4, Toell T5, Siebert U6
1UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Hall in Tirol, Austria, 2Medical Faculty, TU Dresden / UMIT, Dresden / Hall in Tirol, Germany, 3Federal University of Parana, Curitiba, Brazil, 4Faculty of Philosophy, University of Belgrade, Belgrade, Serbia, 5Medical University of Innsbruck, Innsbruck, Austria, 6and Director, Division for HTA, ONCOTYROL – Center for Personalized Cancer Medicine, Hall i.T., Austria

PHS167
E13
HEALTH-RELATED QUALITY OF LIFE OF USERS OF PRIMARY CARE IN BRAZIL
Ascef BO1, Izidoro JB2, Alvares J2, Haddad JP3, Silveira MR2
1Public Health, College of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil, 2College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil, 3Federal University of Minas Gerais, Belo Horizonte, Brazil

PHS168
E14
A QUALITATIVE STUDY TO EXPLORE THE EXPERIENCES OF LUNG CANCER PATIENTS ABOUT DISEASE AND ITS PREVENTION
Azhar S, Khalida S, Bukhari A, Saeed H, Syed A, Murtaza G
Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan

PHS169
E15
KNOWLEDGE, ATTITUDE AND PERCEPTION OF THE GENERAL PUBLIC REGARDING POLIO AND ITS VACCINATION IN KHYBER PAKHTUNKHWA, PAKISTAN. A QUALITATIVE STUDY
Azhar S1, Saeed H2, Syed A1, Khalid S1, Bukhari A1, Murtaza G1
1Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan, 2COMSATS Institute of Information Technology, Abbottabad, Pakistan

PHS170
E16
APPLYING A SIMULATION MODEL TO MANAGE WAITING LISTS FOR HOSPITAL INPATIENT ACTIVITY IN AN EU REGION
Reyes-Santías F1, Martinez-Calvo A2, Vivas-Consuelo D3, Cadarso-Suarez C4
1Universidad de Vigo, Santiago de Compostela, Spain, 2Universidad de Santiago de Compostela (USC), Santiago de Compostela, Spain, 3Universitat Politècnica de València (UPV), Valencia, Spain, 4Universidad de Santiago de Compostela, Santiago de Compostela, Spain

PHS171
E17
HEALTH-RELATED QUALITY OF LIFE OF PATIENTS IN PRIMARY CARE AND MULTIMORBIDITY
Millá-Perseguer M1, Jordán-Alfonso A2, Moreno Ruiz P2, Guadalajara-Olmeda N2, Romero Prada ME3
1Conselleria de Sanitat Universal i Salut Pública, Valencia, Spain, 2Universitat Politècnica de València, Valencia, Spain, 3Fundación Salutia, Bogotá, Colombia

PHS172
E18
THE TRENDS OF EMERGENCY CARE ADMISSIONS FOCUSING ON THE POPULATION OVER 65 YEARS OF AGE
Gresz M1, Farkas Borbás F2
1National Healthcare Service Center, Budapest, Hungary, 2Eötvös Loránd University, Budapest, Hungary

PHS173
E19
ASSESSMENT OF AWARENESS AND KNOWLEDGE OF BREAST CANCER IN PAKISTANI FEMALES; A QUANTITATIVE STUDY
Azhar S, Saeed N, Khalida S, Bukhari A, Saeed H, Syed A
Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan

PHS174
E20
THE EVALUATION HEALTH EDUCATION TO ELEVATE CORRECT MEDICATION KNOWLEDGE AND ABILITY IN COMMUNITY
LEI Y
Mackay Memorial Hospital, Taipei, Taiwan

PHS175
E21
COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING IN AUSTRIA AND ASSESSMENT OF THE IMPACT OF CANCER-CAUSING RISK FACTORS
Gregorich MG1, Urach C2, Breitenecker F1, Zauner G2
1University of Technology Vienna, Vienna, Austria, 2dwh GmbH, Vienna, Austria

PHS176
WITHDRAWN

PHS177
WITHDRAWN

PHS178
E22
WHAT IS THE LEVEL OF TRANSPARENCY IN HEALTH TECHNOLOGY ASSESSMENT PROCESS IN HUNGARY, ROMANIA AND TURKEY?
Subtirelu M1, Mic OC1, Daneasa D2, Csanadi M3, Atikeler K4, Dogan E4, Preda AL5
1University of Medicine and Pharmacy, Craiova, Romania, 2VUB, Free University of Brussels, Brussels, Belgium, 3Syreon Research Institute, Budapest, Hungary, 4Hacettepe University, Ankara, Turkey, 5University of Medicine and Pharmacy „Carol Davila”, Bucharest, Romania

PHS179
E23
EFFECTS OF THE MENTAL HEALTH PARITY AND ADDICTIONS EQUALITY ACT ON DEPRESSION TREATMENT CHOICE IN PRIMARY CARE FACILITIES IN THE UNITED STATES
Goldberg D, Lin H
Indiana University, Bloomington, IN, USA

PHS180
E24
ASSESSING PRIMARY CARE PRACTICE CAPACITY FOR QUALITY IMPROVEMENT: PRELIMINARY FINDINGS FROM HEALTHY HEARTS IN THE HEARTLAND (H3)
Ciesla JR1, Liss DT2, Mazurek KD1, Walunas TL2, Ahmad FS2, Persell SD2
1Northern Illinois University, DeKalb, IL, USA, 2Northwestern University Feinberg School of Medicine, Chicago, IL, USA

PHS181
E25
NOTHING VENTURED, NOTHING GAINED – IS THE INNOVATION FUND THE CATAPULT TO A NEW GENERATION OF CARE CONCEPTS AND A COMPETITIVE MARKET IN HEALTH CARE IN GERMANY?
Droeschel D1, Vollmer L1, Helfrich J2, Walzer S1
1MArS Market Access & Pricing Strategy GmbH, Weil am Rhein, Germany, 2DAK Gesundheit, Hamburg, Germany

PHS182
E26
BARRIERS INFLUENCING IMPLEMENTATION OF GUIDELINES INTO CLINICAL PRACTICE IN CZECH REPUBLIC
Bartakova J1, Moravcikova D2, Rogalewicz V3, Jiskra J4
11st Faculty of Medicine Charles University in Prague, Prague 2, Czech Republic, 2Czech Medical Association of Jan Evangelista Purkyne, Praha10, Czech Republic, 3Czech Technical University in Prague, Kladno, Czech Republic, 4General Faculty Hospital in Prague, Prague 2, Czech Republic

PHS183
E27
ATTITUDES ADHERENCE AND BARRIERS AMONG PUPLICLY EMPLOYED GPS TOWARDS EVIDENCE BASED MEDICINE AND CLINICAL PRACTICE GUIDELINES IN CYPRUS
Panayides N1, Petrou P2, Zinieri B1, Giannakou A3, Ahniotou G2
1Pafos General Hospital, PAFOS, Cyprus, 2Health Insurance Organisation, 1061 Nicosia, Cyprus, 3Open University Cyprus, NICOSIA, Cyprus

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.